This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Jun 1;337(8753):1321-4.

doi: 10.1016/0140-6736(91)92989-f.

Parkinson's disease: pathophysiology

Y Agid¹

Affiliations

PMID: 1674304
DOI: 10.1016/0140-6736(91)92989-f

Review

Parkinson's disease: pathophysiology

Y Agid. Lancet. 1991.

. 1991 Jun 1;337(8753):1321-4.

doi: 10.1016/0140-6736(91)92989-f.

Author

Y Agid¹

Affiliation

¹ Neurology and Neuropsychology Service, Hôpital de la Salpêtrière, Paris, France.

PMID: 1674304
DOI: 10.1016/0140-6736(91)92989-f

No abstract available

PubMed Disclaimer

Similar articles

[Grafted dopaminergic neurons are targeted by the disease process in Parkinson's disease].
Lelan F, Damier P. Lelan F, et al. Med Sci (Paris). 2009 Jan;25(1):15-6. doi: 10.1051/medsci/200925115. Med Sci (Paris). 2009. PMID: 19154684 French. No abstract available.
Assessment of the dopaminergic lesion in Parkinson's disease by CSF markers.
LeWitt PA. LeWitt PA. Adv Neurol. 1993;60:544-7. Adv Neurol. 1993. PMID: 8420188 No abstract available.
Dopamine and Parkinson's disease: is the killer in the house?
Chesselet MF. Chesselet MF. Mol Psychiatry. 2003 Apr;8(4):369-70. doi: 10.1038/sj.mp.4001289. Mol Psychiatry. 2003. PMID: 12740592 No abstract available.
Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
Hirsch EC, Hunot S, Damier P, Brugg B, Faucheux BA, Michel PP, Ruberg M, Muriel MP, Mouatt-Prigent A, Agid Y. Hirsch EC, et al. Adv Neurol. 1999;80:9-18. Adv Neurol. 1999. PMID: 10410697 Review. No abstract available.
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Agid Y, Ruberg M, Javoy-Agid F, Hirsch E, Raisman-Vozari R, Vyas S, Faucheux B, Michel P, Kastner A, Blanchard V, et al. Agid Y, et al. Adv Neurol. 1993;60:148-64. Adv Neurol. 1993. PMID: 8420132 Review. No abstract available.

See all similar articles

Cited by

Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson's Disease.
Sechi GP, Sechi MM. Sechi GP, et al. Int J Mol Sci. 2024 Oct 18;25(20):11198. doi: 10.3390/ijms252011198. Int J Mol Sci. 2024. PMID: 39456980 Free PMC article. Review.
Targeting LRRK2 in Parkinson's disease.
Xiao B, Tan EK. Xiao B, et al. Cell Rep Med. 2022 Oct 18;3(10):100778. doi: 10.1016/j.xcrm.2022.100778. Cell Rep Med. 2022. PMID: 36260987 Free PMC article.
Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson's Disease.
Kolacheva A, Bannikova A, Pavlova E, Bogdanov V, Ugrumov M. Kolacheva A, et al. Int J Mol Sci. 2022 Dec 30;24(1):683. doi: 10.3390/ijms24010683. Int J Mol Sci. 2022. PMID: 36614126 Free PMC article.
Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson's Disease at the Prodromal Stage.
Katunina EA, Blokhin V, Nodel MR, Pavlova EN, Kalinkin AL, Kucheryanu VG, Alekperova L, Selikhova MV, Martynov MY, Ugrumov MV. Katunina EA, et al. Int J Mol Sci. 2023 Jan 17;24(3):1842. doi: 10.3390/ijms24031842. Int J Mol Sci. 2023. PMID: 36768161 Free PMC article.
Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson's Disease as a Manifestation of Neurodegeneration and Neuroplasticity.
Kolacheva A, Alekperova L, Pavlova E, Bannikova A, Ugrumov MV. Kolacheva A, et al. Brain Sci. 2022 Jun 14;12(6):779. doi: 10.3390/brainsci12060779. Brain Sci. 2022. PMID: 35741664 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information